Serratiopeptidase

Serratiopeptidase is a proteolytic enzyme widely used in clinical practice for its anti-inflammatory and anti-edematous properties. Originally derived from Serratia bacteria found in the silkworm intestine, this enzyme has gained significant acceptance in orthopedic, dental, ENT, and post-surgical care for reducing swelling, pain, and tissue inflammation. Unlike conventional painkillers that mainly block pain signals, serratiopeptidase works by breaking down inflammatory proteins and facilitating the natural resolution of tissue edema.

Mechanistically, serratiopeptidase helps degrade non-viable proteins, inflammatory mediators, and fibrin deposits that accumulate at sites of injury or surgery. By improving microcirculation and reducing fluid buildup, it supports faster reduction of swelling and promotes tissue healing. This makes it particularly useful in postoperative recovery, sinus inflammation, soft tissue injuries, and adjunct therapy in musculoskeletal inflammation.

Clinically, serratiopeptidase is often prescribed alongside NSAIDs and antibiotics to enhance overall recovery and improve patient comfort. It is typically recommended to be taken on an empty stomach to maximize systemic absorption. Patients often notice gradual reduction in swelling and improved mobility when the medicine is used consistently as directed.

The enzyme is generally well tolerated, though mild gastrointestinal discomfort or hypersensitivity reactions may rarely occur. Patients with bleeding disorders or those on anticoagulant therapy should use it cautiously under medical supervision. When appropriately prescribed, serratiopeptidase remains a valuable supportive agent in managing inflammatory swelling and promoting smoother recovery after tissue injury.